EL EssilorLuxottica SA

EssilorLuxottica: Full-Year 2022 Results Conference Call Invitation - CORRECT

EssilorLuxottica: Full-Year 2022 Results Conference Call Invitation - CORRECT

Full-Year 2022 Results

Conference Call Invitation

Mr Francesco Milleri, Chairman and Chief Executive Officer

Mr Paul du Saillant, Deputy Chief Executive Officer

Mr Stefano Grassi, Chief Financial Officer, and

Mr Giorgio Iannella, Head of Investor Relations,

have the pleasure of inviting you to our Full-Year 2022 Results Conference Call on:

Thursday, February 23, 2023, at 10:30 am CET

Dial-in telephone access:

If you wish to dial into the conference call, please pre-register at the following link to receive the personal credentials (Dial-in numbers, Conference ID and User ID):

If you encounter any issue in the pre-registration phase you may contact , providing name, surname, and company.

Live webcast:

You can watch the presentation at the following link:

A press release reporting the results will be released at 7 am CET on the same day, and a presentation will be made available prior to the call. Both can be found on .

 

Pièce jointe



EN
13/02/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on EssilorLuxottica SA

 PRESS RELEASE

EssilorLuxottica acquires RetinAI, accelerating transformative AI and ...

EssilorLuxottica acquires RetinAI, accelerating transformative AI and data-powered eye health solutions EssilorLuxottica acquires RetinAI,accelerating transformative AI and data-powered eye health solutions Paris, France (15 October 2025) – EssilorLuxottica announces the acquisition of Ikerian AG, a health technology company, operating under the RetinAI brand, specializing in AI and data management in eyecare. This move reinforces the Group’s med-tech journey, adding advanced software powered by machine learning and computer vision. These solutions streamline clinical, research and pharmac...

 PRESS RELEASE

EssilorLuxottica acquiert RetinAI, accélérant dans les solutions trans...

EssilorLuxottica acquiert RetinAI, accélérant dans les solutions transformatrices de santé de l’œil portées par l'IA et la data EssilorLuxottica acquiert RetinAI, accélérant dans les solutions transformatrices de santé de l’œil portées par l'IA et la data Paris, France (15 octobre 2025) – EssilorLuxottica annonce l'acquisition d'Ikerian AG, une entreprise experte en technologies de santé opérant sous la marque RetinAI, spécialisée dans l'IA et la data. Cette opération renforce la trajectoire med-tech du Groupe, avec des logiciels avancés utilisant des technologies de machine learning et de...

 PRESS RELEASE

EssilorLuxottica acquisisce RetinAI e accelera sullo sviluppo di soluz...

EssilorLuxottica acquisisce RetinAI e accelera sullo sviluppo di soluzioni per la salute degli occhi basate su IA e data science EssilorLuxottica acquisisce RetinAI e accelera sullo sviluppodi soluzioni per la salute degli occhi basate su IA e data science Parigi, Francia (15 ottobre 2025) – EssilorLuxottica annuncia l'acquisizione di Ikerian AG, società che opera con il marchio RetinAI, attiva nell’ambito delle tecnologie medicali e specializzata in IA e gestione dei dati per il settore ottico. L’operazione rafforza la strategia med-tech del Gruppo, integrando software avanzati basati su ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch